Xiaorui Fu

Association between circulating tumor DNA and the prognosis of solid tumor patients receiving neoadjuvant therapy: a meta-analysis

Abstract Background Circulating tumor DNA (ctDNA) has emerged as a promising noninvasive biomarker in solid tumors, yet its prognostic value following neoadjuvant therapy (NAT) warrants systematic validation. Method This study systematically searched databases such as PubMed, Emb...